These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 22677551)

  • 21. MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages.
    Braga TT; Correa-Costa M; Guise YF; Castoldi A; de Oliveira CD; Hyane MI; Cenedeze MA; Teixeira SA; Muscara MN; Perez KR; Cuccovia IM; Pacheco-Silva A; Gonçalves GM; Camara NO
    Mol Med; 2012 Oct; 18(1):1231-9. PubMed ID: 22777483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of PACAP38 on MyD88-mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury.
    Li M; Khan AM; Maderdrut JL; Simon EE; Batuman V
    Am J Nephrol; 2010; 32(6):522-32. PubMed ID: 20980738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia.
    Williams AS; Leung SY; Nath P; Khorasani NM; Bhavsar P; Issa R; Mitchell JA; Adcock IM; Chung KF
    J Appl Physiol (1985); 2007 Oct; 103(4):1189-95. PubMed ID: 17626835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury.
    Ben Mkaddem S; Pedruzzi E; Werts C; Coant N; Bens M; Cluzeaud F; Goujon JM; Ogier-Denis E; Vandewalle A
    Cell Death Differ; 2010 Sep; 17(9):1474-85. PubMed ID: 20224597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells.
    Tsuboi N; Yoshikai Y; Matsuo S; Kikuchi T; Iwami K; Nagai Y; Takeuchi O; Akira S; Matsuguchi T
    J Immunol; 2002 Aug; 169(4):2026-33. PubMed ID: 12165529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury.
    Moreth K; Frey H; Hubo M; Zeng-Brouwers J; Nastase MV; Hsieh LT; Haceni R; Pfeilschifter J; Iozzo RV; Schaefer L
    Matrix Biol; 2014 Apr; 35():143-51. PubMed ID: 24480070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.
    Zhang B; Ramesh G; Uematsu S; Akira S; Reeves WB
    J Am Soc Nephrol; 2008 May; 19(5):923-32. PubMed ID: 18256356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semaphorin 3A inactivation suppresses ischemia-reperfusion-induced inflammation and acute kidney injury.
    Ranganathan P; Jayakumar C; Mohamed R; Weintraub NL; Ramesh G
    Am J Physiol Renal Physiol; 2014 Jul; 307(2):F183-94. PubMed ID: 24829504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect and mechanism of astragaloside Ⅳ on Toll-like receptor pathway in fibrotic mice after renal ischemia-reperfusion].
    Yang RQ; Xu Q; Huangfu ZM; Zhang CL; Yin YF; Zhang J; Zhao CL
    Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(18):3729-3739. PubMed ID: 30384540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor 4: An attractive therapeutic target for acute kidney injury.
    Jha AK; Gairola S; Kundu S; Doye P; Syed AM; Ram C; Murty US; Naidu VGM; Sahu BD
    Life Sci; 2021 Apr; 271():119155. PubMed ID: 33548286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
    Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
    Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zingerone ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting Toll-like receptor 4 signaling pathway.
    Song J; Fan HJ; Li H; Ding H; Lv Q; Hou SK
    Eur J Pharmacol; 2016 Feb; 772():108-14. PubMed ID: 26698392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion.
    Li JH; Tang Y; Lv J; Wang XH; Yang H; Tang PMK; Huang XR; He ZJ; Zhou ZJ; Huang QY; Klug J; Meinhardt A; Fingerle-Rowson G; Xu AP; Zheng ZH; Lan HY
    J Cell Mol Med; 2019 Jun; 23(6):3867-3877. PubMed ID: 30968541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathways.
    Sachdev U; Cui X; McEnaney R; Wang T; Benabou K; Tzeng E
    PLoS One; 2012; 7(11):e50654. PubMed ID: 23209800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.
    Lin M; Yiu WH; Wu HJ; Chan LY; Leung JC; Au WS; Chan KW; Lai KN; Tang SC
    J Am Soc Nephrol; 2012 Jan; 23(1):86-102. PubMed ID: 22021706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel ameliorates lipopolysaccharide-induced kidney injury by binding myeloid differentiation protein-2 to block Toll-like receptor 4-mediated nuclear factor-κB activation and cytokine production.
    Zhang D; Li Y; Liu Y; Xiang X; Dong Z
    J Pharmacol Exp Ther; 2013 Apr; 345(1):69-75. PubMed ID: 23318472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury.
    Chen J; John R; Richardson JA; Shelton JM; Zhou XJ; Wang Y; Wu QQ; Hartono JR; Winterberg PD; Lu CY
    Kidney Int; 2011 Feb; 79(3):288-99. PubMed ID: 20927041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal expression of Toll-like receptor 2 and 4: dynamics in human allograft injury and comparison to rodents.
    Stribos EG; van Werkhoven MB; Poppelaars F; van Goor H; Olinga P; van Son WJ; Damman J; Seelen MA
    Mol Immunol; 2015 Mar; 64(1):82-9. PubMed ID: 25465639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.